arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Definitive Healthcare Corp.

$0.70 ▲ +0.02 (+2.25%) at close

8 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Definitive Healthcare Corp. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $74.7M

Dividend Yield —

Revenue Growth -4.2% ↘

Op. Margin -92.9% ↗

ROIC -128.5% ↗

FCF / Share $0.35 ↘

Trailing P/E —

Price / Book —

FCF Yield 49.6%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$241.52M

↓ -4.2% —

Net Income Profit after all expenses

$-138.93M

↑ +66.4% —

Operating Margin Operating profit as % of sales

-92.9%

↑ +67.1% 2th

FCF / Share Free cash flow per share

$0.35

↓ -11.6% —

Long-Term Debt Long-term obligations

$166.25M

↓ -31.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-4.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-135%)	0.3% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-97%)	12.9% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8%)	34.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+183%)	40.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+237%)	—	—	—
EPS Growth YoY (%)	63.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-97.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-2883.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	68.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	66.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-104.1% Weak ↑ Weak Improving Year-over-year change in net income	-3252.5% Weak ↓ Weak Declining Year-over-year change in net income	65.8% Excellent Excellent Year-over-year change in net income	65.4% Excellent Excellent Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	-11.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	16.0% Good ↓ Good Declining Year-over-year change in free cash flow	25.7% Excellent Excellent Year-over-year change in free cash flow	34.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	2.7% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	14.9% Good Good Compound annual revenue growth over 3 years	28.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	15.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-92.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-564%)	-281.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1509%)	-131.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-756%)	-18.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-193%)	-15.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-175%)	-12.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-161%)	—	—
Effective Tax Rate (%) (%)	4.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	43.6% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	-57.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-483%)	-163.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1192%)	-80.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-637%)	-2.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-118%)	-10.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-171%)	-43.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-388%)	—	—
FCF Margin (%) (%)	15.3% Good → Good Stable Free cash flow as a percentage of revenue Optimal: > 10%	18.2% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	15.2% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	12.2% Fair ↓ Fair Declining Free cash flow as a percentage of revenue Optimal: > 10%	11.1% Fair Fair Free cash flow as a percentage of revenue Optimal: > 10%	18.4% Good Good Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	-0.27x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.11x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.19x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-4.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-128.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-271.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-120.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-3.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-30.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-65.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	-19.87x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-47.91x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-21.69x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.90x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.97x Weak Weak Operating income divided by interest expense Optimal: > 5x	-0.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$2.62M	$138.69M	$126.84M	$119.47M	$-123.69M	$432.42M	$-17.06M	$-19.36M
Debt / EBITDA (x)	-0.75x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.34x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.79x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-6.82x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-11.36x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-34.39x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$2.26	$2.16	$2.23	$2.20	$1.81	—	—	—
Basic EPS, GAAP (USD)	$-1.30	$-3.54	$-1.79	$-0.06	$-0.19	—	—	—
Free Cash Flow per Share (USD)	$0.35	$0.39	$0.34	$0.27	$0.20	—	—	—
Basic Weighted Avg Shares (shares)	106.65M	116.64M	112.76M	101.11M	91.92M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$100.82M	$209.01M	$223.25M	$281.24M	$326.44M	$-24.88M	—	—
LT Debt (USD)	$166.25M	$244.06M	$257.81M	$266.41M	$263.81M	$457.20M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$241.52M	$252.20M	$251.41M	$222.65M	$166.15M	$118.32M	—	—
Depreciation Expense (USD)	$3.30M	$2.25M	$1.95M	$2.19M	$1.75M	$1.15M	—	—
Net Income, GAAP (USD)	$-138.93M	$-413.12M	$-202.39M	$-6.04M	$-17.68M	$-51.16M	—	—
Operating Cash Flow (USD)	$53.78M	$58.20M	$41.19M	$35.58M	$25.21M	$23.22M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 25 quarters

Definitive Healthcare Corp.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare DH with peers